Company intelligence / Profile preview

Inoveon

Oklahoma City, Oklahoma, United Statesolsfventures.com ↗

Ownership: Private
Development stage: Other

Overview

Inoveon developed and commercialized retinal imaging systems for early detection and monitoring of diabetic retinopathy and other eye diseases. Their technology improved compliance rates for annual eye evaluations among diabetes patients at clinical sites such as the Oklahoma City VA Medical Center. By 2002, they had completed over 10,000 patient evaluations with their system. The company was later acquired.

Therapeutic areas: Ophthalmology
Modalities: DeviceDiagnostic service (retinal imaging systems)
Industry: Medical Imaging

Beyond the preview

Go deeper on Inoveon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inoveon.

Explore the full profile